Neuropace Inc (NPCE)
$12.30 -5.46% Close Oct 30, 2026 Live
Neuropace stock today
Neuropace closed at $12.30 on October 30, 2026, down 5.46% on the day. Over the past year it returned +24.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $419 million.
$10.00$15.00
NovJan 2026MarMayJulSep
| Period | NPCE | S&P 500 (SPY) |
|---|---|---|
| 1 month | -10.6% | -0.9% |
| 3 months | -10.5% | +2.1% |
| Year to date | -20.3% | +11.7% |
| 1 year | +24.7% | +12.4% |
| 3 years | +85.2% | +88.5% |
| 5 years | -18.9% | +76.0% |
Key statistics
- Market value
- $419M
- Price / sales
- 4.2
- 52-week range
- $9.40 to $19.29
- Next report
- Nov 12, 2026
About Neuropace
NeuroPace develops implantable neurostimulation devices for treating epilepsy and brain disorders.
Sector: Health Care
More on Neuropace
- Financials: revenue, earnings and segmentsRevenue +25% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $811.35 today
No forecast, no recommendation. This page describes Neuropace Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.